Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Department of Pathology, UMC Utrecht, Utrecht, the Netherlands.
Cell Genom. 2024 Nov 13;4(11):100675. doi: 10.1016/j.xgen.2024.100675. Epub 2024 Oct 14.
In pediatric cancer, structural variants (SVs) and copy-number alterations contribute to cancer initiation as well as progression, thereby aiding diagnosis and treatment stratification. Although suggested to be of importance, the prevalence and biological relevance of complex genomic rearrangements (CGRs) across pediatric solid tumors is largely unexplored. In a cohort of 120 primary tumors, we systematically characterized patterns of extrachromosomal DNA, chromoplexy, and chromothripsis across five pediatric solid cancer types. CGRs were identified in 56 tumors (47%), and in 42 of these tumors, CGRs affect cancer driver genes or result in unfavorable chromosomal alterations. This demonstrates that CGRs are prevalent and pathogenic in pediatric solid tumors and suggests that selection likely contributes to the structural variation landscape. Moreover, carrying CGRs is associated with more adverse clinical events. Our study highlights the potential for CGRs to be incorporated in risk stratification or exploited for targeted treatments.
在儿科癌症中,结构变异(SVs)和拷贝数改变有助于癌症的发生和进展,从而有助于诊断和治疗分层。尽管已经提出了重要性,但复杂基因组重排(CGRs)在儿科实体瘤中的普遍性和生物学相关性在很大程度上仍未得到探索。在一个包含 120 个原发性肿瘤的队列中,我们系统地描述了五种儿科实体癌类型中染色体外 DNA、染色体重组和染色体重排的模式。在 56 个肿瘤(47%)中发现了 CGRs,在其中 42 个肿瘤中,CGRs 影响癌症驱动基因或导致不利的染色体改变。这表明 CGRs 在儿科实体瘤中普遍存在且具有致病性,并表明选择可能有助于结构变异景观。此外,携带 CGRs 与更多不良临床事件相关。我们的研究强调了 CGRs 有可能被纳入风险分层或被用于靶向治疗。